Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Telmisartan 80mg / Hydrochlorothiazide 12.5mg tablets
0205052R0AAABAB
|
Telmisartan/hydrochlorothiazide | Telmisartan with diuretic | Cardiovascular System | 4,202 |
|
Telmisartan 40mg / Hydrochlorothiazide 12.5mg tablets
0205052R0AAAAAA
|
Telmisartan/hydrochlorothiazide | Telmisartan with diuretic | Cardiovascular System | 2,724 |
|
Telmisartan 80mg / Hydrochlorothiazide 25mg tablets
0205052R0AAACAC
|
Telmisartan/hydrochlorothiazide | Telmisartan with diuretic | Cardiovascular System | 1,008 |
|
MicardisPlus 80mg/12.5mg tablets
0205052R0BBABAB
|
MicardisPlus | Telmisartan with diuretic | Cardiovascular System | 577 |
|
MicardisPlus 40mg/12.5mg tablets
0205052R0BBAAAA
|
MicardisPlus | Telmisartan with diuretic | Cardiovascular System | 312 |
|
MicardisPlus 80mg/25mg tablets
0205052R0BBACAC
|
MicardisPlus | Telmisartan with diuretic | Cardiovascular System | 163 |
|
Actelsar HCT 80mg/25mg tablets
0205052R0BCACAC
|
Actelsar | Telmisartan with diuretic | Cardiovascular System | 5 |
|
Actelsar HCT 40mg/12.5mg tablets
0205052R0BCAAAA
|
Actelsar | Telmisartan with diuretic | Cardiovascular System | No data available |
|
Actelsar HCT 80mg/12.5mg tablets
0205052R0BCABAB
|
Actelsar | Telmisartan with diuretic | Cardiovascular System | No data available |
|
Tolucombi 40mg/12.5mg tablets
0205052R0BDAAAA
|
Tolucombi | Telmisartan with diuretic | Cardiovascular System | No data available |
|
Tolucombi 80mg/12.5mg tablets
0205052R0BDABAB
|
Tolucombi | Telmisartan with diuretic | Cardiovascular System | No data available |
|
Tolucombi 80mg/25mg tablets
0205052R0BDACAC
|
Tolucombi | Telmisartan with diuretic | Cardiovascular System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.